The Use of Directed Evolution to Create a Stable and Immunogenic Recombinant BCG Expressing a Modified HIV-1 Gag Antigen

Numerous features make Mycobacterium bovis BCG an attractive vaccine vector for HIV. It has a good safety profile, it elicits long-lasting cellular immune responses and in addition manufacturing costs are affordable. Despite these advantages it is often difficult to express viral antigens in BCG, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Rosamund, Bourn, William R., Shephard, Enid, Stutz, Helen, Douglass, Nicola, Mgwebi, Thandi, Meyers, Ann, Chin'ombe, Nyasha, Williamson, Anna-Lise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111510/
https://www.ncbi.nlm.nih.gov/pubmed/25061753
http://dx.doi.org/10.1371/journal.pone.0103314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111510/
https://www.ncbi.nlm.nih.gov/pubmed/25061753
http://dx.doi.org/10.1371/journal.pone.0103314

Ejemplares similares